BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Oct 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-10-28

Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-28	Common Stock	M	16875	$14.39	Acquired	63353	Direct
2011-10-28	Common Stock	S	16875	$35.00	Disposed	46478	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-28	Stock Option (right to buy)	$14.39	M	16875	Disposed	2019-05-11	Common Stock (16875)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 25, 2011.

F2: Original option vests 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.